Anti-mouse FcγRIV antibody 9E9 also blocks FcγRIII in vivo.
Antibody and Vaccine Group, Cancer Sciences Unit, University of Southampton Faculty of Medicine, Southampton, United Kingdom.
Thomas R W
TR
Tipton
Antibody and Vaccine Group, Cancer Sciences Unit, University of Southampton Faculty of Medicine, Southampton, United Kingdom.
C Ian
CI
Mockridge
Antibody and Vaccine Group, Cancer Sciences Unit, University of Southampton Faculty of Medicine, Southampton, United Kingdom.
Ruth R
RR
French
Antibody and Vaccine Group, Cancer Sciences Unit, University of Southampton Faculty of Medicine, Southampton, United Kingdom.
Alison L
AL
Tutt
Antibody and Vaccine Group, Cancer Sciences Unit, University of Southampton Faculty of Medicine, Southampton, United Kingdom.
Mark S
http://orcid.org/0000-0003-2077-089X
MS
Cragg
Antibody and Vaccine Group, Cancer Sciences Unit, University of Southampton Faculty of Medicine, Southampton, United Kingdom.
Stephen A
http://orcid.org/0000-0002-3765-3342
SA
Beers
D019264:Adoptive Transfer; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D000918:Antibody Specificity; D000937:Antigen-Antibody Reactions; D018951:Antigens, CD20 / Q000276:immunology; D003429:Cross Reactions; D006801:Humans; D008212:Lymphocyte Depletion; D008264:Macrophages / Q000276:immunology; D051379:Mice; D008822:Mice, Transgenic; D017452:Receptors, IgG / Q000276:immunology*; D013154:Spleen / Q000166:cytology
D000911:Antibodies, Monoclonal; D018951:Antigens, CD20; C485700:Fcgr3 protein, mouse; C522404:Fcgr4 protein, mouse; D017452:Receptors, IgG